-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gastric cancer is the fifth most common cancer and the fourth largest cause of cancer-related deaths due to stomach cancer is common in Asia, the Asian countries have a large number of patients with gastric cancer is in advanced stages of diagnosis out
.
Although systemic therapy has improved, the survival rate of patients with advanced gastric cancer is still limited
Gastric cancer is the fifth most common cancer and the fourth largest cause of cancer-related deaths due to stomach cancer is common in Asia, the Asian countries have a large number of patients with gastric cancer is in advanced stages of diagnosis out
The research plan is mainly to include patients with advanced gastric cancer (hemoglobin level <8.
0 g/dL) who meet the blood transfusion standards into this study
.
The primary endpoint is the intention-to-treat (ITT) bleeding response rate at 4 weeks
A total of 55 patients from 15 medical institutions were recruited for this study
.
At 2, 4, and 8 weeks, the ITT response rates were 47%, 53%, and 49%, respectively
At the end of the study, the author stated that this study proved that patients who received relatively low radiation doses had a higher response rate to palliative care
.
Palliative radiotherapy may be very effective in improving anemia, but it is mildly toxic
At the end of the study, the author stated that this study proved that patients who received relatively low radiation doses had a higher response rate to palliative care
Original source:
Tetsuo Saito.
Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3).
Leave a message here